The MRX Group of 300+ Global Corporations with operations in 27 time zones.
Neil Gerardo Chair & CEO MRX Global Holding Corporation
The next generation of healthcare is the convergence of smartphones and biosensors. Personal Medical Electronics for diagnostics, monitoring and therapeutics. Emerging as Digital Health, e-health, electronically enhanced medicine, m-health and mobile health.
Molecular specific targeted medical therapies for the in vivo elimination of differentiated virus, bacteria and numerous forms of cancer, utilizing molecular specific absorption targeting.
The ability to selectively and precisely ablate biological tissue is a natural candidate for the treatment of cancer, heart disease and HIV. Remote molecular specific detection, differentiation and mitigation of virus, bacteria, arterial plaque, amyloid plaque and numerous differentiated cancers, without collateral damage to contiguous salubrious cells. Research in transferring and adapting remote molecular specific technologies from U.S. defense and intelligence agencies into medical applications.